29 / 164
FINANCIAL SITUATION
29
LISI 2015 FINANCIAL REPORT
Investments are still significant (€4.0 million) and carried
in particular by the increase in production capacities and
equipment renewal. In addition, new logistics approaches
lowered the inventory rotation rate from 80 days of sales
revenue in 2014 to 77 days in 2015. Consequently, free cash flow
returned to positive figures over the financial year, at +€1.7
million (compared to -€1.0 million in 2014), i.e. 2.3% of sales
revenue.
The industrial system and the qualified personnel of the
different sites are able to manage the future level of activity.
OUTLOOK
After the significant increase in activity, the LISI MEDICAL
division starts the 2016 financial year on the basis of fairly
stable outlooks with consolidated fundamentals, and improved
production facilities adapted to current volumes. The
development of new products with new customers remains a
priority to feed growth drivers for all the sites.
Qualitative objectives for 2016 are in the continuity of the
improvement approach underway for the last three years.